PMC:7212965 / 24467-24747 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T190","span":{"begin":29,"end":36},"obj":"http://purl.obolibrary.org/obo/CLO_0001013"},{"id":"T191","span":{"begin":29,"end":36},"obj":"http://purl.obolibrary.org/obo/CLO_0052464"}],"text":"% (95% CI, 13.3%–16.6%).37 , 46 , 47 , 59 , 63 , 68 , 70 This is in comparison to the prevalence of symptoms in studies from China, which was 5.2% (95% CI, 4.4%–5.9%) (Figure 2 and Supplementary Figure 7).\nFigure 2 Forest plot of the prevalence of nausea/vomiting in all patients."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T106","span":{"begin":248,"end":263},"obj":"Phenotype"}],"attributes":[{"id":"A106","pred":"hp_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/HP_0002017"}],"text":"% (95% CI, 13.3%–16.6%).37 , 46 , 47 , 59 , 63 , 68 , 70 This is in comparison to the prevalence of symptoms in studies from China, which was 5.2% (95% CI, 4.4%–5.9%) (Figure 2 and Supplementary Figure 7).\nFigure 2 Forest plot of the prevalence of nausea/vomiting in all patients."}

{"project":"2_test","denotations":[{"id":"32407808-32192580-43469290","span":{"begin":29,"end":31},"obj":"32192580"},{"id":"32407808-32519944-43469291","span":{"begin":49,"end":51},"obj":"32519944"}],"text":"% (95% CI, 13.3%–16.6%).37 , 46 , 47 , 59 , 63 , 68 , 70 This is in comparison to the prevalence of symptoms in studies from China, which was 5.2% (95% CI, 4.4%–5.9%) (Figure 2 and Supplementary Figure 7).\nFigure 2 Forest plot of the prevalence of nausea/vomiting in all patients."}

{"project":"LitCovid-sentences","denotations":[{"id":"T166","span":{"begin":206,"end":280},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"% (95% CI, 13.3%–16.6%).37 , 46 , 47 , 59 , 63 , 68 , 70 This is in comparison to the prevalence of symptoms in studies from China, which was 5.2% (95% CI, 4.4%–5.9%) (Figure 2 and Supplementary Figure 7).\nFigure 2 Forest plot of the prevalence of nausea/vomiting in all patients."}

{"project":"LitCovid-PubTator","denotations":[{"id":"561","span":{"begin":271,"end":279},"obj":"Species"},{"id":"562","span":{"begin":248,"end":254},"obj":"Disease"},{"id":"563","span":{"begin":255,"end":263},"obj":"Disease"}],"attributes":[{"id":"A561","pred":"tao:has_database_id","subj":"561","obj":"Tax:9606"},{"id":"A562","pred":"tao:has_database_id","subj":"562","obj":"MESH:D009325"},{"id":"A563","pred":"tao:has_database_id","subj":"563","obj":"MESH:D014839"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"% (95% CI, 13.3%–16.6%).37 , 46 , 47 , 59 , 63 , 68 , 70 This is in comparison to the prevalence of symptoms in studies from China, which was 5.2% (95% CI, 4.4%–5.9%) (Figure 2 and Supplementary Figure 7).\nFigure 2 Forest plot of the prevalence of nausea/vomiting in all patients."}